GYKI-52466 is a selective, non-competitive AMPA receptor antagonist with micromolar potency, showing high selectivity for AMPA over kainate and NMDA receptors. It is utilized in research as a neuroprotective agent, an anticonvulsant, and a skeletal muscle relaxant in various in vivo models of neurological disorders.